Comparison of non-invasive treatment through the nose for the treatment of respiratory immaturity in preterm neonates

Not Applicable

• Conditions: treatment.; Respiratory distress of newborn; p22, p22.0

• Registration Number: IRCT2014072618598N1
• Lead Sponsor: Hamedan University of Medical Scinences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

All consecutively born preterm infants with gestational age between 28 to 34 weeks, admitted to Fatemiyeh neonatal intensive care unit with respiratory distress syndrome
approved RDS; gestational age between 28 to 34 weeks; neonates with 72 hours age after delivery.
Exclusioncriteria: the neonates aith APGAR score less than 3 at five minute after birth; those whom mother had rupture of the membrane for more than three weeks; severe malformation; chromosomal anomalies such as trisomy of 13,18 and 21; pneumonia; pneumothorax

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Survival rates in 7days. Timepoint: during hospitalization and using NIPPV and NCPAP. Method of measurement: comparing survival rates.

Secondary Outcome Measures

Name	Time	Method
eed to mechanical ventilation. Timepoint: during hospitalization and using NIPPV and NCPAP. Method of measurement: during hospitalization and using NIPPV and NCPAP.;Lung hemorhage. Timepoint: during hospitalization and using NIPPV and NCPAP. Method of measurement: during hospitalization and using NIPPV and NCPAP.;Pnemothorax. Timepoint: during hospitalization and using NIPPV and NCPAP. Method of measurement: during hospitalization and using NIPPV and NCPAP.;NEC. Timepoint: during hospitalization and using NIPPV and NCPAP. Method of measurement: during hospitalization and using NIPPV and NCPAP.;Sepsis. Timepoint: during hospitalization and using NIPPV and NCPAP. Method of measurement: during hospitalization and using NIPPV and NCPAP.;Mortality. Timepoint: during hospitalization and using NIPPV and NCPAP. Method of measurement: during hospitalization and using NIPPV and NCPAP.